Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

O9637

Sigma-Aldrich

Oxaprozin

solid

Synonym(s):

4,5-Diphenyl-2-oxazolepropanoic acid, Daypro

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C18H15NO3
CAS Number:
21256-18-8
Molecular Weight:
293.32
EC Number:
244-296-1
MDL number:
MFCD00215977
UNSPSC Code:
12352200
PubChem Substance ID:
24278617
NACRES:
NA.77

form

solid

SMILES string

OC(=O)CCc1nc(-c2ccccc2)c(o1)-c3ccccc3

InChI

1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)

InChI key

OFPXSFXSNFPTHF-UHFFFAOYSA-N

Gene Information

human ... PTGIR(5739) , PTGS1(5742) , PTGS2(5743)

Looking for similar products? Visit Product Comparison Guide

General description

Oxaprozin is a non-steroidal anti-inflammatory drug prescribed for rheumatoid arthritis (RA) and osteoarthritis (OA). Oxaprozin binds to albumin. It inhibits arachidonic acid pathway. Oxaprozin has anti-inflammatory property and is an effective inhibitor of cyclooxygenase enzymes, COX-1 and COX-2.

Application

Anti-inflammatory

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Recent pharmacodynamic and pharmacokinetic findings on oxaprozin
Rainsford KD, et al.
Inflammopharmacology, 10(3), 185-239 (2002)
Allen Brinker et al.
Drugs & aging, 21(7), 479-484 (2004-05-11)
Data on file with the US FDA, and other published studies, suggest that the selective cyclo-oxygenase (COX)-2 inhibitor NSAID rofecoxib has a greater hypertensive adverse effect than other NSAIDs, including celecoxib. In this study we describe a pharmacoepidemiologic analysis of
Shao-Fa Sun et al.
International journal of biological macromolecules, 39(4-5), 197-200 (2006-07-11)
The interaction between Oxaprozin-E and bovine serum albumin (BSA) was studied by spectroscopic methods including fluorescence and UV-vis absorption spectroscopy. The quenching mechanism of fluorescence of BSA by Oxaprozin-E was discussed to be a dynamic quenching procedure. The number of
Paola Mura et al.
Journal of microencapsulation, 27(6), 479-486 (2010-02-02)
A combined approach based on drug cyclodextrin (CD) complexation and loading into PLGA nanoparticles (NP) has been developed to improve oxaprozin therapeutic efficiency. This strategy exploits the solubilizing and stabilizing properties of CDs and the prolonged-release and targeting properties of
Zhidong Liu et al.
The Journal of pharmacy and pharmacology, 58(1), 45-50 (2006-01-06)
Our purpose was to explore the use of Transcutol P (Trans) in an ocular drug delivery system. The effect of Trans on the corneal permeability of drugs was investigated in-vitro, using isolated rabbit corneas. The ocular irritation of Trans was
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service